Evidence map›Paper›PMID 40200867›Full record

ArticleMovement disorders clinical practice2025

Use of and Barriers to Subcutaneous Apomorphine Pen Injections in Parkinson's Disease: A Survey by the French NS-PARK Network.

Mickael Aubignat, Fatma Khelifi, Olivier Rascol, NS‐PARK/FCRIN Network

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mickael AubignatDepartment of Neurology and Movement Disorders, Expert Center for Parkinson's Disease, NS-PARK Network, Amiens Picardie University Hospital, Amiens, France.ORCID https://orcid.org/0000-0001-5183-1128
Fatma KhelifiNS-PARK Network and Clinical Investigation Center CIC1436, INSERM, Toulouse, France.
Olivier RascolDepartment of Clinical Pharmacology and Neurosciences, Expert Center for Parkinson's Disease, Clinical Investigation Center CIC1436 and NS-PARK Network, Toulouse University Hospital and INSERM, Toulouse, France.ORCID https://orcid.org/0000-0002-1410-6397
NS‐PARK/FCRIN Network

Funding

FUNDAÇÃO BIAL
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apomorphineParkinson's diseasepractice

Identifiers

PMID40200867
PMCPMC12371466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.